These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31211918)

  • 21. Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension.
    Gorelova A; Berman M; Al Ghouleh I
    Antioxid Redox Signal; 2021 Apr; 34(12):891-914. PubMed ID: 32746619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aspirin ameliorates pulmonary vascular remodeling in pulmonary hypertension by dampening endothelial-to-mesenchymal transition.
    Huang N; Zhu TT; Liu T; Ge XY; Wang D; Liu H; Zhu GX; Zhang Z; Hu CP
    Eur J Pharmacol; 2021 Oct; 908():174307. PubMed ID: 34245748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Twist1 in Hypoxia-induced Pulmonary Hypertension through Transforming Growth Factor-β-Smad Signaling.
    Mammoto T; Muyleart M; Konduri GG; Mammoto A
    Am J Respir Cell Mol Biol; 2018 Feb; 58(2):194-207. PubMed ID: 28915063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
    Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
    Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation and characterization of endothelial-to-mesenchymal transition cells in pulmonary arterial hypertension.
    Suzuki T; Carrier EJ; Talati MH; Rathinasabapathy A; Chen X; Nishimura R; Tada Y; Tatsumi K; West J
    Am J Physiol Lung Cell Mol Physiol; 2018 Jan; 314(1):L118-L126. PubMed ID: 28935639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exosomes derived from mesenchymal stromal cells exert a therapeutic effect on hypoxia-induced pulmonary hypertension by modulating the YAP1/SPP1 signaling pathway.
    Chen YX; Deng ZH; Xue-Gao ; Qiang-Du ; Juan-Yin ; Chen GH; Li JG; Zhao YM; Zhang HT; Zhang GX; Qian JX
    Biomed Pharmacother; 2023 Dec; 168():115816. PubMed ID: 37918254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow derived mesenchymal stem cells inhibit inflammation and preserve vascular endothelial integrity in the lungs after hemorrhagic shock.
    Pati S; Gerber MH; Menge TD; Wataha KA; Zhao Y; Baumgartner JA; Zhao J; Letourneau PA; Huby MP; Baer LA; Salsbury JR; Kozar RA; Wade CE; Walker PA; Dash PK; Cox CS; Doursout MF; Holcomb JB
    PLoS One; 2011; 6(9):e25171. PubMed ID: 21980392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monocrotaline-Induced Pulmonary Hypertension Involves Downregulation of Antiaging Protein Klotho and eNOS Activity.
    Varshney R; Ali Q; Wu C; Sun Z
    Hypertension; 2016 Nov; 68(5):1255-1263. PubMed ID: 27672025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-27a promotes endothelial-mesenchymal transition in hypoxia-induced pulmonary arterial hypertension by suppressing BMP signaling.
    Liu T; Zou XZ; Huang N; Ge XY; Yao MZ; Liu H; Zhang Z; Hu CP
    Life Sci; 2019 Jun; 227():64-73. PubMed ID: 31004656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The synergistic therapeutic effect of hepatocyte growth factor and granulocyte colony-stimulating factor on pulmonary hypertension in rats.
    Guo Y; Su L; Li Y; Guo N; Xie L; Zhang D; Zhang X; Li H; Zhang G; Wang Y; Liu C
    Heart Vessels; 2014 Jul; 29(4):520-31. PubMed ID: 23933910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticle endothelial delivery of PGC-1α attenuates hypoxia-induced pulmonary hypertension by attenuating EndoMT-caused vascular wall remodeling.
    Cai D; Chen SY
    Redox Biol; 2022 Dec; 58():102524. PubMed ID: 36334380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesenchymal stem cells attenuate vascular remodeling in monocrotaline-induced pulmonary hypertension rats.
    Xie J; Hu D; Niu L; Qu S; Wang S; Liu S
    J Huazhong Univ Sci Technolog Med Sci; 2012 Dec; 32(6):810-817. PubMed ID: 23271278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension.
    Kanki-Horimoto S; Horimoto H; Mieno S; Kishida K; Watanabe F; Furuya E; Katsumata T
    Circulation; 2006 Jul; 114(1 Suppl):I181-5. PubMed ID: 16820570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic effects of hypoxia-preconditioned bone marrow-derived mesenchymal stromal cells and their extracellular vesicles in experimental pulmonary arterial hypertension.
    Braga CL; Santos RT; da Silva CM; de Novaes Rocha N; Felix NS; Medeiros M; Melo MM; Silva JD; Teixeira DE; Neves CC; Rocco PRM; Cruz FF; Silva PL
    Life Sci; 2023 Sep; 329():121988. PubMed ID: 37517581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIMF (Hypoxia-Induced Mitogenic Factor) Signaling Mediates the HMGB1 (High Mobility Group Box 1)-Dependent Endothelial and Smooth Muscle Cell Crosstalk in Pulmonary Hypertension.
    Lin Q; Fan C; Gomez-Arroyo J; Van Raemdonck K; Meuchel LW; Skinner JT; Everett AD; Fang X; Macdonald AA; Yamaji-Kegan K; Johns RA
    Arterioscler Thromb Vasc Biol; 2019 Dec; 39(12):2505-2519. PubMed ID: 31597444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow mesenchymal stem cells and condition media diminish inflammatory adhesion molecules of pulmonary endothelial cells in an ovalbumin-induced asthmatic rat model.
    Rahbarghazi R; Keyhanmanesh R; Aslani MR; Hassanpour M; Ahmadi M
    Microvasc Res; 2019 Jan; 121():63-70. PubMed ID: 30343002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial-to-mesenchymal transition in pulmonary hypertension.
    Ranchoux B; Antigny F; Rucker-Martin C; Hautefort A; Péchoux C; Bogaard HJ; Dorfmüller P; Remy S; Lecerf F; Planté S; Chat S; Fadel E; Houssaini A; Anegon I; Adnot S; Simonneau G; Humbert M; Cohen-Kaminsky S; Perros F
    Circulation; 2015 Mar; 131(11):1006-18. PubMed ID: 25593290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CAR (CARSKNKDC) Peptide Modified ReNcell-Derived Extracellular Vesicles as a Novel Therapeutic Agent for Targeted Pulmonary Hypertension Therapy.
    Wang J; Hu L; Huang H; Yu Y; Wang J; Yu Y; Li K; Li Y; Tian T; Chen F
    Hypertension; 2020 Oct; 76(4):1147-1160. PubMed ID: 32829668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A ring N(CH
    Kong S; Yu J; Li HF; Xie YL; Song LF; Wang QQ; Chen YJ; Zhao FR; Zhang WF; Zhu TT
    Eur J Pharmacol; 2023 Nov; 959():176077. PubMed ID: 37820784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of bone marrow mesenchymal stem cell transplantation on hypoxic pulmonary hypertension in rats].
    Tian HJ; Yang JP; Wang XX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2014 May; 30(3):233-6. PubMed ID: 25244789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.